| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| H-Val-Val-Gln-OH |
H-VAL-VAL-GLN-OH |
212207-62-0 |
詳細
|
| H-Val-Val-Lys-OH |
H-Val-Val-Lys-OH |
73015-99-3 |
詳細
|
| H-Val-Val-OH |
H-VAL-VAL-OH |
3918-94-3 |
詳細
|
| H-Val-Val-Phe-OH |
H-VAL-VAL-PHE-OH |
153247-47-3 |
詳細
|
| H-Val-Val-Val-OH |
H-VAL-VAL-VAL-OH |
28130-13-4 |
詳細
|
| H-Val-Val-Val-Val-OH |
H-VAL-VAL-VAL-VAL-OH |
64577-64-6 |
詳細
|
| HY Peptide [246-254] |
H-WMHHNMDLI-OH |
|
詳細
|
| Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) |
ILE-THR-ASP-GLN-VAL-PRO-PHE-SER-VAL: ITDQVPFSV |
162558-10-3 |
詳細
|
| Immunstimulating Peptide, human |
VAL-GLU-PRO-ILE-PRO-TYR: VEPIPY |
|
詳細
|
| Imperatoxin A |
歐前胡素A |
172451-37-5 |
詳細
|
| Indolicidin;ILPWKWPWWPWRR-NH2 |
抗菌肽Indolicidin |
140896-21-5 |
詳細
|
| Influenza A M2 coat protein (22-46)??;SSDPLVVAASIIGILHLILWILDRL |
SER-SER-ASP-PRO-LEU-VAL-VAL-ALA-ALA-SER-ILE-ILE-GLY-ILE-LEU-HIS-LEU-ILE-LEU-TRP-ILE-LEU-ASP-ARG-LEU |
|
詳細
|
| Hymenistatin I |
HYMENISTATIN I |
1173938-18-5 |
詳細
|
| Hypercalcemia Malignancy Factor (7-34), amide, human;LLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2 |
115695-30-2 |
詳細
|
| Hypertrehalosaemic Neuropeptide, Heliothis zea;Pyr-LTFSSGWGN-NH2 |
PYR-LEU-THR-PHE-SER-SER-GLY-TRP-GLY-ASN-NH2 |
117107-54-7 |
詳細
|
| Hypocretin-1-Gly (Rat, Mouse) |
LEU-GLY-VAL-ASP-ALA-GLN-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-LEU-GLY |
|
詳細
|
| Iberiotoxin |
IBERIOTOXIN毒素肽 |
129203-60-7 |
詳細
|
| IDR-1 |
IDR-1 |
940291-10-1 |
詳細
|
| IFN-α Receptor Recognition Peptide 1 (IRRP1) |
IFN-Α RECEPTOR RECOGNITION PEPTIDE 1 (IRRP1) |
|
詳細
|
| IFN-γ Antagonist |
IFN-Γ ANTAGONIST |
|
詳細
|
| Insulin-Like Growth Factor I (24-41) |
TYR-PHE-ASN-LYS-PRO-THR-GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR |
135861-49-3 |
詳細
|
| Insulin-Like Growth Factor II (33-40) |
SER-ARG-VAL-SER-ARG-ARG-SER-ARG |
103244-41-3 |
詳細
|
| IL-1 Receptor Peptide (human) |
IL-1 RECEPTOR PEPTIDE (HUMAN) |
141801-03-8 |
詳細
|
| IL-1a (223-250) (human) |
PHE-PHE-TYR-GLU-THR-HIS-GLY-THR-LYS-ASN-TYR-PHE-THR-SER-VAL-ALA-HIS-PRO-ASN-LEU-PHE-ILE-ALA-THR-LYS-GLN-ASP-TYR |
|
詳細
|
| IL-1β (163-171) (human) |
IL-1Β (163-171) (HUMAN) |
|
詳細
|
| Interleukin-6 (88-121), human |
ILE-ILE-THR-GLY-LEU-LEU-GLU-PHE-GLU-VAL-TYR-LEU-GLU-TYR-LEU-GLN-ASN-ARG-PHE-GLU-SER-SER-GLU-GLU-GLN-ALA-ARG-ALA-VAL-GLN-MET-SER-THR-LYS |
145990-81-4 |
詳細
|
| Ile-Arg-Ile-Cys(Me)-Arg-Lys-Gly-NH2 |
ILE-ARG-ILE-CYS(ME)-ARG-LYS-GLY-NH2 |
|
詳細
|
| Influenza HA (307-319);PKYVKQNTLKLAT |
PRO-LYS-TYR-VAL-LYS-GLN-ASN-THR-LEU-LYS-LEU-ALA-THR |
528526-85-4 |
詳細
|
| Influenza HA (518-526);IYSTVASSL |
ILE-TYR-SER-THR-VAL-ALA-SER-SER-LEU |
186302-15-8 |
詳細
|
| Influenza HA (529-537);IYATVAGSL |
ILE-TYR-ALA-THR-VAL-ALA-GLY-SER-LEU |
|
詳細
|
| Influenza NP (147-155);TYQRTRALV |
THR-TYR-GLN-ARG-THR-ARG-ALA-LEU-VAL |
132326-72-8 |
詳細
|
| Influenza NP (482-489);SNEGSYFF |
SER-ASN-GLU-GLY-SER-TYR-PHE-PHE |
|
詳細
|
| INSL 4 A Chain / Insulin-like 4 A Chain (Human) |
SER-GLY-ARG-HIS-ARG-PHE-ASP-PRO-PHE-CYS-CYS(ACM)-GLU-VAL-ILE-CYS-ASP-ASP-GLY-THR-SER-VAL-LYS-LEU-CYS-THR |
|
詳細
|
| Insulin B (22-25) |
INSULIN B (22-25) |
34367-73-2 |
詳細
|
| Insulin-Like Growth [Tyr0] Factor II (33-40) |
TYR-SER-ARG-VAL-SER-ARG-ARG-SER-ARG |
|
詳細
|
| H-Val-β-Ala-OH |
纈氨酰-丙氨酸 |
27493-61-4 |
詳細
|
| PKC Substrate 2;VRKRTLRRL |
H-VAL-ARG-LYS-ARG-THR-LEU-ARG-ARG-LEU-OH |
105802-82-2 |
詳細
|
| H-Val-Asp-OH |
H-VAL-ASP-OH |
20556-16-5 |
詳細
|
| H-Val-D-Pro-Pro-OH |
H-VAL-D-PRO-PRO-OH |
|
詳細
|
| H-Val-Gln-OH |
H-VAL-GLN-OH |
42854-54-6 |
詳細
|
| H-Val-Gly-Gly-OH |
H-VAL-GLY-GLY-OH |
21835-35-8 |
詳細
|
| H-Val-Gly-NH2 · HCl |
H-VAL-GLY-NH2 · HCL |
98035-61-1 |
詳細
|
| H-Val-Gly-OH |
H-VAL-GLY-OH |
686-43-1 |
詳細
|
| H-Val-His-Leu-Thr-Pro-OH |
H-VAL-HIS-LEU-THR-PRO-OH |
93913-38-3 |
詳細
|
| H-Val-Ile-His-Thr-EDANS |
H-VAL-ILE-HIS-THR-EDANS |
|
詳細
|
| H-Val-Ile-OH |
H-VAL-ILE-OH |
20556-14-3 |
詳細
|
| H-Val-Leu-Lys-pNA · 2 HCl |
H-VAL-LEU-LYS-PNA · 2 HCL |
|
詳細
|
| H-Val-Leu-OH · HCl |
L-亮氨酸L-戊基鹽酸鹽（1：1） |
95977-55-2 |
詳細
|
| H-Val-Leu-Ser-Glu-Gly-OH |
H-VAL-LEU-SER-GLU-GLY-OH |
83178-69-2 |
詳細
|
| H-Val-Leu-Ser-OH |
H-VAL-LEU-SER-OH |
|
詳細
|
| H-Val-Lys-Lys-Arg-OH |
H-VAL-LYS-LYS-ARG-OH |
286471-39-4 |
詳細
|
| H-Val-Lys-OH |
H-VAL-LYS-OH |
|
詳細
|
| H-Val-Lys-OH · HCl |
H-VAL-LYS-OH · HCL |
|
詳細
|
| H-Val-Met-OH |
L-纈氨酰-L-蛋氨酸 |
14486-09-0 |
詳細
|
| H-Val-Phe-NH2 · HCl |
H-VAL-PHE-NH2 · HCL |
129678-27-9 |
詳細
|
| Human Parainfluenza Virus Type 3 Fusion Protein (454-488) (acetylated) |
HUMAN PARAINFLUENZA VIRUS TYPE 3 FUSION PROTEIN (454-488) (ACETYLATED) |
|
詳細
|
| Humanin, HN;MAPRGFSCLLLLTSEIDLPVKRRA |
護腦素(人體) |
330936-69-1 |
詳細
|
| H-Val-Ala-Ala-Phe-OH |
H-VAL-ALA-ALA-PHE-OH |
21957-32-4 |
詳細
|
| H-Val-Phe-OH |
H-VAL-PHE-OH |
3918-92-1 |
詳細
|
| H-Val-Pro-Pro-OH |
H-VAL-PRO-PRO-OH |
58872-39-2 |
詳細
|
| H-Val-Ser-OH |
H-VAL-SER-OH |
13588-94-8 |
詳細
|
| V-T-C-G |
H-VAL-THR-CYS-GLY-OH |
131204-46-1 |
詳細
|
| H-Val-Tyr-OH |
H-VAL-TYR-OH |
3061-91-4 |
詳細
|
| H-Val-Tyr-Pro-OH |
H-VAL-TYR-PRO-OH |
68076-97-1 |
詳細
|
| H-Val-Tyr-Ser-βNA |
H-VAL-TYR-SER-ΒNA |
13989-68-9 |
詳細
|
| H-Val-Tyr-Val-OH |
H-VAL-TYR-VAL-OH |
17355-22-5 |
詳細
|
| H-Tyr-Tyr-NH2 · HCl |
H-TYR-TYR-NH2 · HCL |
|
詳細
|
| H-Tyr-Tyr-OH |
H-TYR-TYR-OH |
1050-28-8 |
詳細
|
| H-Tyr-Tyr-Phe-NH2 |
H-TYR-TYR-PHE-NH2 |
117756-23-7 |
詳細
|
| H-Tyr-Tyr-Tyr-OH |
L-酪氨酰-L-酪氨酰-L-酪氨酸 |
7390-78-5 |
詳細
|
| Human CMV Assemblin Protease Inhibitor |
HUMAN CMV ASSEMBLIN PROTEASE INHIBITOR |
166603-46-9 |
詳細
|
| Dipeptide-2 |
二肽-2 |
24587-37-9 |
詳細
|
| H-Tyr-Tyr-Tyr-OMe |
H-TYR-TYR-TYR-OME |
53566-70-4 |
詳細
|
| H-Tyr-Val-OH |
H-TYR-VAL-OH |
17355-09-8 |
詳細
|
| H-Val-Pro-OH · HCl |
H-VAL-PRO-OH · HCL |
105931-64-4 |
詳細
|
| H-Val-Gly-Asp-Glu-OH |
H-VAL-GLY-ASP-GLU-OH |
63141-66-2 |
詳細
|
| Influenza HA (210-219);TYVSVGTSTL |
THR-TYR-VAL-SER-VAL-GLY-THR-SER-THR-LEU |
|
詳細
|
| IL-1b (208-240) (human) |
LYS-LYS-LYS-MET-GLU-LYS-ARG-PHE-VAL-PHE-ASN-LYS-ILE-GLU-ILE-ASN-ASN-LYS-LEU-GLU-PHE-GLU-SER-ALA-GLN-PHE-PRO-ASN-TRP-TYR-ILE-SER-THR |
|
詳細
|
| IL-1b (178-207) (human) |
LEU-LYS-GLU-LYS-ASN-LEU-TYR-LEU-SER-CYS-VAL-LEU-LYS-ASP-ASP-LYS-PRO-THR-LEU-GLN-LEU-GLU-SER-VAL-ASP-PRO-LYS-ASN-TYR-PRO |
|
詳細
|
| IELLQAR (8-branch MAPS) Selectin Binding Peptide;IELLQAR |
ILE-GLU-LEU-LEU-GLN-ALA-ARG |
|
詳細
|
| I-309 (human) |
LYS-SER-MET-GLN-VAL-PRO-PHE-SER-ARG-CYS-CYS-PHE-SER-PHE-ALA-GLU-GLN-GLU-ILE-PRO-LEU-ARG-ALA-ILE-LEU-CYS-TYR-ARG-ASN-THR-SER-SER-ILE-CYS-SER-ASN-GLU-GLY-LEU-ILE-PHE-LYS-LEU-LYS-ARG-GLY-LYS-GLU-ALA-CYS-ALA-LEU-ASP-THR-VAL-GLY-TRP-VAL-GLN-ARG-HIS-ARG-LYS-MET |
|
詳細
|
| Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea |
HYPERTREHALOSAEMIC NEUROPEPTIDE (NAUPHOETA CINEREA) |
106018-36-4 |
詳細
|
| Influenza HA (110-120);SFERFEIFPKE |
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS-GLU |
|
詳細
|
| Influenza HA (110-119);SFERFEIFPK |
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS |
132031-50-6 |
詳細
|
| H-Tyr-Tyr-Phe-OH |
H-TYR-TYR-PHE-OH |
|
詳細
|
| H-Val-Tyr-NH2 · HCl |
H-VAL-TYR-NH2 · HCL |
126712-17-2 |
詳細
|
| H-Val-Trp-Ile-OH |
H-VAL-TRP-ILE-OH |
|
詳細
|
| H-Val-Pro-OtBu · HCl |
H-VAL-PRO-OTBU · HCL |
60108-51-2 |
詳細
|
| H-Val-His-OH |
H-VAL-HIS-OH |
13589-07-6 |
詳細
|
| H-Val-Glu-OH |
H-VAL-GLU-OH |
3062-07-5 |
詳細
|
| H-Val-Asn-OH |
H-VAL-ASN-OH |
66170-00-1 |
詳細
|
| H-Val-Arg-OH |
H-VAL-ARG-OH |
37682-75-0 |
詳細
|
| H-Val-Ala-pNA |
H-VAL-ALA-PNA |
87810-63-7 |
詳細
|
| Insulin Receptor (689-702) |
INSULIN RECEPTOR (689-702) |
|
詳細
|
| Insulin Receptor (1142-1153);TRDIYETDYYRK |
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS-NH2 |
|
詳細
|
| Insulin B (9-23) ??;SHLVEALYLVCGERG |
NH2-SHLVEALYLVCGERG-OH |
|
詳細
|
| Influenza NP (50-57);SDYEGRLI |
SER-ASP-TYR-GLU-GLY-ARG-LEU-ILE |
|
詳細
|
| Influenza HA (204-212);LYQNVGTYV |
LEU-TYR-GLN-ASN-VAL-GLY-THR-TYR-VAL |
|
詳細
|
| Inactivation Gate Peptide |
INACTIVATION GATE PEPTIDE |
156162-44-6 |
詳細
|
| H-Val-Val-Val-NH2 · HBr |
H-VAL-VAL-VAL-NH2 · HBR |
|
詳細
|